Volume 8 Issue 3
Decoding Melanoma Metastasis
William E. Damsky,Lara E. Rosenbaum andMarcus Bosenberg
1Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA
2Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA
*Author to whom correspondence should be addressed.
Abstract
Metastasis accounts for the vast majority of morbidity and mortality associated with melanoma. Evidence suggests melanoma has a predilection for metastasis to particular organs. Experimental analyses have begun to shed light on the mechanisms regulating melanoma metastasis and organ specificity, but these analyses are complicated by observations of metastatic dormancy and dissemination of melanocytes that are not yet fully malignant. Additionally, tumor extrinsic factors in the microenvironment, both at the site of the primary tumor and the site of metastasis, play important roles in mediating the metastatic process. As metastasis research moves forward, paradigms explaining melanoma metastasis as a step-wise process must also reflect the temporal complexity and heterogeneity in progression of this disease. Genetic drivers of melanoma as well as extrinsic regulators of disease spread, particularly those that mediate metastasis to specific organs, must also be incorporated into newer models of melanoma metastasis.Keywords: melanoma; metastasis; organ-specific; metastatic dormancy; pre-malignant dissemination